Insights
Reynolds ENDS Section 337 Investigation Concludes: Asserted Claims Invalid, No General Exclusion Order
Author
Hongchang Deng · 邓宏昌
美国(加州)执业律师(Bar #354529)· USPTO · 中国专利代理师
Yi Yi · 易伊
美国(加州)执业律师
Published
2026-03-19 · 33 min read
TL;DR
On March 10, 2026, the Commission reversed the ALJ and held every asserted claim — including claims 4 and 12, previously found valid and infringed — invalid as obvious. The investigation terminated with no violation and no GEO.
In brief: On March 10, 2026, the U.S. International Trade Commission issued its final Commission Opinion in investigation 337-TA-1410, concluding a patent fight of nearly two years that had the vape industry's full attention. The Commission reversed the ALJ's Final Initial Determination (FID) and held that every claim Reynolds asserted — including claims 4 and 12, which the ALJ had found valid and infringed — is invalid as obvious. The investigation terminated with a finding of no violation, and the general exclusion order (GEO) the industry had most feared did not issue.
01 | Where the Case Stood
Our previous note, published in February 2026, covered the Commission's decision to review the ALJ's FID in part. The open questions were whether claims 4 and 12 would be held obvious over the combination of Kim and Pienemann, and whether the GEO and the 136% bond would ultimately take effect.
The answers are now in, and the Commission reached the conclusion most favorable to the industry:
- Claims 1, 4, and 12 are all invalid as obvious under § 103.
- The finding that Takeuchi does not anticipate claims 4 and 12 stands.
- The investigation terminated with a finding of no violation of Section 337.
- No general exclusion order, limited exclusion order, or cease and desist order issued.
- The 136% bond requirement does not apply.
02 | Why the Commission Reversed
2.1 The Core Error
In the FID, the ALJ concluded that respondents had failed to establish that the porous chip of the Kim patent satisfied the key limitation of claim 1 of the '202 patent — that the liquid aerosol-forming material be drawn into contact with the resistive heater by wicking (limitation 1[e]).
The ALJ's reasoning was that Kim does not expressly discuss wicking, that respondents' expert Dr. Dean testified too generally, and that the slider knob in the Kim device itself indicates that the liquid need not wick.
The Commission was explicit: that analytical approach is wrong.
2.2 Obviousness Does Not Require That the Prior Art Necessarily Disclose the Element
The ALJ's fundamental error was conflating the obviousness analysis with the standard for inherent anticipation. Inherency requires that an element be necessarily present in the prior art. The obviousness question is not whether Kim discusses wicking, but:
Would a person of ordinary skill in the art (POSA), given what Kim discloses, have been motivated to use a wicking material to make the porous chip?
The Commission answered yes, for the following reasons:
- Kim expressly requires that the porous chip absorb liquid into its pores and readily release it once vaporized.
- Wicking is a basic physical principle established since the mid-nineteenth century and universally known in the art.
- Without a wicking material, liquid at the far end of the chip would be unusable where the heater does not reach it — wasteful, given that Kim expressly contemplates the chip storing roughly two weeks' supply.
- Although Reynolds's expert argued that wicking is inconsistent with the slider knob, the Commission concluded that this only shows the two may be used together and complement one another, not that they are mutually exclusive.
- Commercial design constraints (heat resistance, taste, and so on) are not required by the claims and cannot affect the POSA's obviousness analysis.
2.3 Claim 4: The Aerosol Passes At Least Partially Through the Reservoir
The ALJ found that respondents' expert had misconstrued "the aerosol that is produced," which per limitation 1[f] is a mixture of liquid vapor and outside air rather than vaporized liquid alone. The Commission accepted that construction but concluded the ALJ had read Dr. Dean's testimony too narrowly.
The key is that claim 4 uses "at least partially through." Kim's porous chip is full of pores and interconnected structures, and vaporized liquid leaving the chip necessarily mixes with outside air entering those pores — mixing that occurs at least partially within the chip. The Commission found this not only obvious but difficult, if not unavoidable, to prevent.
2.4 Claim 12: The Heater Permits Airflow
The ALJ concluded that Kim's heating coil, to fit within the central channel of the porous chip, would have to be wound so tightly as to create creases and weld points that would block airflow. The Commission found that conclusion overlooked key facts:
- Kim expressly discloses the central channel, which is wide enough for the chip to move back and forth under the slider knob.
- Kim never requires that any portion be completely sealed.
- The coil's material, wire gauge, number of turns, diameter, and spacing from the chip — design variables well known in the art — can all be adjusted to permit some degree of airflow.
- Even Reynolds's expert Mr. Alarcon acknowledged that the design parameters Dr. Dean identified were known in the art.
The Commission noted that the governing standard is KSR: combining known elements according to their known functions to yield predictable results is generally obvious. KSR Int'l Co. v. Teleflex, Inc., 550 U.S. 398 (2007).
03 | Takeuchi Anticipation: No Anticipation, Affirmed
On whether Takeuchi anticipates claims 4 and 12, the Commission affirmed the ALJ's finding of no anticipation, while adding an important analysis.
Respondents argued that during the replenishment phase of the Takeuchi device, as liquid evaporates from the reservoir tube and creates a void, outside air briefly flows into the tube, passes through the annular heater (satisfying claim 12), and mixes with residual vapor (satisfying claim 4).
The Commission responded that even if such a phenomenon were theoretically possible, respondents' expert offered no calculation, simulation, or data establishing that it actually occurs. Takeuchi's capillary inner diameter falls within an optimal range of 0.1–0.8 mm, where capillary action is very strong and liquid can refill a void within milliseconds — leaving no time window for outside air to enter.
A trace amount can support anticipation (as in SmithKline), but only where that trace is the necessary result of the prior art product's operation. A trace that is merely possible, or probable, does not meet the standard of proof for anticipation.
That is a substantive addition to the FID, clarifying the boundaries of de minimis anticipation and of significant reference value for comparable cases.
04 | Procedure: Obviousness Was Not Waived
Reynolds raised a procedural argument: that respondents before the ALJ had largely argued that Kim disclosed the relevant elements rather than genuinely asserting obviousness, and had therefore waived it.
The Commission disagreed, for three reasons:
- Respondents and Dr. Dean asserted obviousness expressly throughout the proceeding.
- The ALJ's own summary regarding claim 12 acknowledged that respondents had made an obviousness argument, contradicting footnote 105 of the FID.
- Respondents' theory did not require modifying Kim; it asserted that Kim's known elements were obvious within a POSA's technical knowledge — a legitimate § 103 analysis.
That treatment matters in practice: in a Section 337 investigation, obviousness and inherent disclosure arguments may be advanced in parallel. They address different aspects of a continuum and should not be treated as severed.
05 | What the Outcome Means for the Industry
5.1 The GEO Threat Is Fully Lifted
This is the most immediate effect. In the RD, the ALJ had recommended a GEO covering all disposable atomizer products infringing claims 4 and 12, regardless of whether the importer was a respondent. Had it issued, nearly all Chinese-manufactured disposable vape products would have faced an import bar.
Because the Commission held every asserted claim invalid, no GEO could issue, and the industry retains market access. In addition, the '202 patent itself expires on October 18, 2026 — so even had it been upheld, little of its term remained.
5.2 Lessons for Patent Portfolio Strategy
The case exposes a strategic weakness: Reynolds's position rested entirely on a handful of claims of the '202 patent, and the core independent claim 1 was already invalid as anticipated at the FID stage. The infringement case was therefore structurally fragile; once the Commission also reversed on obviousness, Reynolds was left with nothing.
That is a precedent worth attention for complainants who mount a Section 337 campaign on a single patent. Portfolio depth and breadth matter. A Section 337 action built on one patent and a limited set of claims carries substantial risk where respondents have the resources to mount an effective validity challenge.
5.3 The Common-Sense Dimension of Obviousness
The Commission repeatedly invoked the principle established in KSR: a POSA's logic, judgment, and common sense are part of the obviousness analysis, and the inquiry should not be confined to the literal text of the prior art. That position favors accused infringers, meaning a validity defense may draw on broader technical background knowledge without locating a word-for-word disclosure for every element.
5.4 The Absence of Secondary Considerations
Notably, Reynolds never offered objective evidence of non-obviousness — commercial success, unexpected results, industry praise — at any point in the proceeding, and the Commission expressly noted it. In future Section 337 cases, a patentee facing an obviousness defense should prepare and submit such evidence systematically.
06 | What Became of the Lashify Standard Here
Our previous note described Lashify's revision of the domestic industry standard in detail. Here, the ALJ applied the new standard and found Reynolds's sales network and quality control investment (including its FDA PMTA expenditures) sufficient to satisfy the economic prong.
On review, the Commission took a pragmatic position: with every asserted claim invalid, whether the economic prong was satisfied no longer mattered, and the Commission took no position. The technical prong — whether Reynolds's products practice a valid claim of the '202 patent — was affirmed.
Viewed more broadly, the Lashify standard did operate here, helping Reynolds clear the domestic industry threshold and carry the case through to the merits. Its effect on future Section 337 investigations continues: a lower threshold for complainants to bring an action, and correspondingly less room for respondents to contest domestic industry.
07 | Practical Implications for Pending and Potential Section 337 Cases
7.1 The Value of a Validity Challenge
The clearest lesson here is that a systematic challenge to validity can change the trajectory of a Section 337 investigation entirely. In Section 337 practice, invalidity is a complete defense: if the patent is invalid, there is no violation regardless of infringement. Respondents' willingness to invest in a fully expert-supported validity case ultimately reversed the entire matter.
7.2 Defaulted Respondents and What Comes Next
Under the Commission's March 10, 2026 final opinion, the investigation terminated with no violation, and no exclusion order, cease and desist order, or bond requirement issued. That determination should apply to all respondents, including those in default, and there is no import bar risk at this stage. We suggest continuing to monitor through March 24, 2026 (the deadline for a petition for reconsideration) and May 10, 2026 (expiration of the appeal period), to confirm whether Reynolds initiates further proceedings.
08 | The Key Determinations Side by Side
| Claim 1 | Claims 4 & 12 | GEO / Relief | |
|---|---|---|---|
| ALJ Final Initial Determination | Infringed but invalid as anticipated (claims 1, 9, 11, 15) | Valid and infringed | GEO + 136% bond recommended |
| Commission Final Opinion | Invalid as obvious under § 103 | Invalid as obvious under § 103 | No violation; no remedial orders |
| Practical effect | Asserted claims substantially all invalid | All infringement allegations fall away | Import channel remains open |
09 | Closing: A Reversal Worth Recording
Investigation 337-TA-1410 ran nearly two years from filing to termination, passing through a denied TEO, an FID finding infringement, and a recommended GEO — each highly adverse to the industry — only to end with every asserted claim invalid and a finding of no violation.
That outcome was not accidental. It came from respondents' systematic preparation on validity and an accurate grasp of obviousness analysis under the KSR framework. The Commission expressly corrected the ALJ's conflation of obviousness with inherent anticipation, providing an important reference point for validity defenses in comparable cases.
For vape companies focused on the U.S. market, perhaps the most important message is this: facing a Section 337 investigation, appearing and preparing a thorough validity defense remains a viable path to reversing an unfavorable position.
This article addresses general legal questions only and does not constitute legal advice on any specific matter.
关于作者 / About the Authors
Partner · LawMay P.C.
邓律师主要从事中国及美国商品及服务争议解决,以及专利、商标、版权、商业秘密等涉外知识产权诉讼与无效确权业务,并办理中美商标申请及中国专利申请。常年服务跨境工贸企业、跨境电商、电子烟行业、科技制造业等领域,为财富 500 强、国际连锁品牌、出海科技品牌等多家中外知名企业提供常年及专项法律服务。
在跨境电商争议领域,邓律师专注 Schedule A 批量诉讼的被告应对,包括临时限制令(TRO)项下的店铺账户与资金解冻、通过确认不侵权之诉(Declaratory Judgment,DJ)与「反向 TRO」动议争取恢复被下架的商品链接与店铺经营,以及亚马逊账户冻结申诉、品牌备案(Brand Registry)争议等平台纠纷的代理。在华盛顿州西区联邦法院,邓律师代理多起确认不侵权之诉(DJ),取得了恢复商品上架、并禁止对方继续投诉的「反向 TRO」与「反向初步禁令(反向 PI)」。他熟悉 Schedule A 案件高发的伊利诺伊州北区、佛州南区等联邦法院的程序节奏,能在中美时差下迅速响应、把握应诉与和解的时间窗口。
在涉外电子烟与 FDA 监管领域,邓律师为电子烟及新型烟草企业提供覆盖确权、合规到维权的全流程代理,涵盖行业知识产权维权与 337 调查、PMTA 上市前申请与 STN 状态争议、FDA 执法防御(警告信、营销拒绝令 MDO、进口扣留 Import Alert),以及美国海关(CBP)清关合规与扣押货物申诉。
他代理的知识产权相关案件多次荣获「广东省知识产权行政保护典型案例」「广东省商业秘密保护大事件」、「深圳律师承办知识产权十大典型案例」、「深圳市侵害商业秘密典型案例」、「深圳律师国际贸易、投资领域典型案例」、「广东知识产权保护协会年度知识产权推荐学习案例」等专业荣誉。
他代理的商品及服务贸易纠纷、知识产权等争议解决案件涉案标的额总计达数十亿元人民币。
美国联邦知识产权诉讼 · 跨境工贸与电商争议 · 电子烟与 FDA 监管 · 商业秘密与不正当竞争
Non-Equity Partner · LawMay P.C.
易伊是美国加利福尼亚州执业律师,执业领域主要包括美国联邦法院知识产权诉讼、跨境电商争议、产品责任纠纷及联邦上诉案件。易伊代理中国及其他国际客户处理专利侵权、商标及著作权争议、产品责任纠纷、临时限制令与初步禁令、网络平台知识产权执法及其他跨境商事纠纷。
易伊经常协助客户应对临时限制令及初步禁令申请,挑战不当的管辖权主张,制定专利不侵权及无效抗辩,并协调中美两地的诉讼策略。易伊亦为跨境电商企业就知识产权执法、平台账户及商品链接争议、产品责任索赔及相关诉讼风险提供法律服务。
易伊具备在美国联邦巡回上诉法院、美国第十一巡回上诉法院、加州中区、北区联邦地区法院及德克萨斯东区、南区、伊利诺伊州北区联邦地区法院的出庭经验(涵盖正式执业资格与临时出庭许可 Pro Hac Vice / PHV 两种形式)。易伊亦办理美国专利商标局商标申请事务,并为美国知识产权法律协会会员。
美国联邦知识产权诉讼 · 跨境电商争议解决 · 联邦巡回上诉法院实务
About LawMay P.C.
美国路迈律师事务所(LawMay P.C.)
深耕中美跨境争议解决的美国精品律所。专注于美国联邦知识产权诉讼、337 调查、产品责任纠纷及重大商事争议。
Law May, We May.